Loading…
The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37
The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was great...
Saved in:
Published in: | Journal of antimicrobial chemotherapy 1991-12, Vol.28 (6), p.843-853 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3 |
---|---|
cites | |
container_end_page | 853 |
container_issue | 6 |
container_start_page | 843 |
container_title | Journal of antimicrobial chemotherapy |
container_volume | 28 |
creator | Bojar, Richard A. Holland, Keith T. Cunliffe, William J. |
description | The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis. |
doi_str_mv | 10.1093/jac/28.6.843 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72709285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72709285</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3</originalsourceid><addsrcrecordid>eNqFkE1rVDEUQIModVrduRWyEFd903znZSnVsUJLi1Qo3YQk7wZT38c0eU_UX2-GGepS7uIuzuFyOQi9oWRNieFnDy6csXat1q3gz9CKCkUaRgx9jlaEE9loIflLdFzKAyFESdUeoSOqmaLKrND97XfAaWx-pjlP2I1zGlLIk0-uxxAjhLngKWL3B3qXAnYhdXjZTiO-ydM2TWPyLsyQ0zJUNkLBZc4uVcz1K_Qiur7A68M-Qd82n27PL5rL689fzj9cNoEZMzeikx3xoHfjhQycOJD1b9pF7hkJQUXRgRFREqqI9Eo5BbrzlJoYfQf8BL3f393m6XGBMtshlQB970aYlmI108SwVv5XpIpSYchOPN2LtUQpGaLd5jS4_NtSYnfNbW1uWWuVrc2r_vZwd_EDdP_kfeTK3x24K8H1MbsxpPKkSdoKKVnVmr2Wygy_nrDLP6zSXEt7cXdvr242H-80_Wo3_C_MB5l0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16114905</pqid></control><display><type>article</type><title>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Bojar, Richard A. ; Holland, Keith T. ; Cunliffe, William J.</creator><creatorcontrib>Bojar, Richard A. ; Holland, Keith T. ; Cunliffe, William J.</creatorcontrib><description>The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/28.6.843</identifier><identifier>PMID: 1726169</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Proteins - biosynthesis ; Biological and medical sciences ; Culture Media ; Dermatologic Agents - metabolism ; Dermatologic Agents - pharmacology ; Dicarboxylic Acids - metabolism ; Dicarboxylic Acids - pharmacology ; DNA, Bacterial - biosynthesis ; Hydrogen-Ion Concentration ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Propionibacterium acnes - drug effects ; Propionibacterium acnes - growth & development ; Propionibacterium acnes - metabolism ; RNA, Bacterial - biosynthesis ; Species Specificity ; Temperature</subject><ispartof>Journal of antimicrobial chemotherapy, 1991-12, Vol.28 (6), p.843-853</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5184552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1726169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bojar, Richard A.</creatorcontrib><creatorcontrib>Holland, Keith T.</creatorcontrib><creatorcontrib>Cunliffe, William J.</creatorcontrib><title>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.</description><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Proteins - biosynthesis</subject><subject>Biological and medical sciences</subject><subject>Culture Media</subject><subject>Dermatologic Agents - metabolism</subject><subject>Dermatologic Agents - pharmacology</subject><subject>Dicarboxylic Acids - metabolism</subject><subject>Dicarboxylic Acids - pharmacology</subject><subject>DNA, Bacterial - biosynthesis</subject><subject>Hydrogen-Ion Concentration</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Propionibacterium acnes - drug effects</subject><subject>Propionibacterium acnes - growth & development</subject><subject>Propionibacterium acnes - metabolism</subject><subject>RNA, Bacterial - biosynthesis</subject><subject>Species Specificity</subject><subject>Temperature</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNqFkE1rVDEUQIModVrduRWyEFd903znZSnVsUJLi1Qo3YQk7wZT38c0eU_UX2-GGepS7uIuzuFyOQi9oWRNieFnDy6csXat1q3gz9CKCkUaRgx9jlaEE9loIflLdFzKAyFESdUeoSOqmaLKrND97XfAaWx-pjlP2I1zGlLIk0-uxxAjhLngKWL3B3qXAnYhdXjZTiO-ydM2TWPyLsyQ0zJUNkLBZc4uVcz1K_Qiur7A68M-Qd82n27PL5rL689fzj9cNoEZMzeikx3xoHfjhQycOJD1b9pF7hkJQUXRgRFREqqI9Eo5BbrzlJoYfQf8BL3f393m6XGBMtshlQB970aYlmI108SwVv5XpIpSYchOPN2LtUQpGaLd5jS4_NtSYnfNbW1uWWuVrc2r_vZwd_EDdP_kfeTK3x24K8H1MbsxpPKkSdoKKVnVmr2Wygy_nrDLP6zSXEt7cXdvr242H-80_Wo3_C_MB5l0</recordid><startdate>199112</startdate><enddate>199112</enddate><creator>Bojar, Richard A.</creator><creator>Holland, Keith T.</creator><creator>Cunliffe, William J.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>199112</creationdate><title>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</title><author>Bojar, Richard A. ; Holland, Keith T. ; Cunliffe, William J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Proteins - biosynthesis</topic><topic>Biological and medical sciences</topic><topic>Culture Media</topic><topic>Dermatologic Agents - metabolism</topic><topic>Dermatologic Agents - pharmacology</topic><topic>Dicarboxylic Acids - metabolism</topic><topic>Dicarboxylic Acids - pharmacology</topic><topic>DNA, Bacterial - biosynthesis</topic><topic>Hydrogen-Ion Concentration</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Propionibacterium acnes - drug effects</topic><topic>Propionibacterium acnes - growth & development</topic><topic>Propionibacterium acnes - metabolism</topic><topic>RNA, Bacterial - biosynthesis</topic><topic>Species Specificity</topic><topic>Temperature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bojar, Richard A.</creatorcontrib><creatorcontrib>Holland, Keith T.</creatorcontrib><creatorcontrib>Cunliffe, William J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bojar, Richard A.</au><au>Holland, Keith T.</au><au>Cunliffe, William J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1991-12</date><risdate>1991</risdate><volume>28</volume><issue>6</issue><spage>843</spage><epage>853</epage><pages>843-853</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>1726169</pmid><doi>10.1093/jac/28.6.843</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-7453 |
ispartof | Journal of antimicrobial chemotherapy, 1991-12, Vol.28 (6), p.843-853 |
issn | 0305-7453 1460-2091 |
language | eng |
recordid | cdi_proquest_miscellaneous_72709285 |
source | Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025 |
subjects | Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial Proteins - biosynthesis Biological and medical sciences Culture Media Dermatologic Agents - metabolism Dermatologic Agents - pharmacology Dicarboxylic Acids - metabolism Dicarboxylic Acids - pharmacology DNA, Bacterial - biosynthesis Hydrogen-Ion Concentration Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Propionibacterium acnes - drug effects Propionibacterium acnes - growth & development Propionibacterium acnes - metabolism RNA, Bacterial - biosynthesis Species Specificity Temperature |
title | The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A09%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20in-vitro%20antimicrobial%20effects%20of%20azelaic%20acid%20upon%20Propionibacterium%20acnes%20strain%20P37&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Bojar,%20Richard%20A.&rft.date=1991-12&rft.volume=28&rft.issue=6&rft.spage=843&rft.epage=853&rft.pages=843-853&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/28.6.843&rft_dat=%3Cproquest_cross%3E72709285%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16114905&rft_id=info:pmid/1726169&rfr_iscdi=true |